Clinical Evaluation of Siemens SARS-CoV-2 Total Antibody assay and IgG assay using the Dimension EXL 200 in the Tokyo Metropolitan area

Background: We evaluated the efficacy of the Siemens SARS-CoV-2 Total Antibody assay (CV2T) and IgG assay (CV2G) that can detect antibodies against the receptor binding domain of S antigen in patients with COVID-19 in a Tokyo metropolitan area. Methods: Sensitivity and antibody levels were examined...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gene Igawa, Takamasa Yamamoto, Yuna Baba, Konomi Shinozuka, Maiko Yuri, Mitsuru Wakita, Shigeki Misawa, Takashi Miida, Tomohiko Ai, Yoko Tabe
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/764d44d58d874542a60686004259eff7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!